🇺🇸 Taxane in United States

39 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 39

Most-reported reactions

1. Disease Progression — 12 reports (30.77%)
2. Drug Resistance — 7 reports (17.95%)
3. Therapy Non-Responder — 5 reports (12.82%)
4. Interstitial Lung Disease — 3 reports (7.69%)
5. Ejection Fraction Decreased — 2 reports (5.13%)
6. Malignant Neoplasm Progression — 2 reports (5.13%)
7. Neuropathy Peripheral — 2 reports (5.13%)
8. Neutropenia — 2 reports (5.13%)
9. Ovarian Cancer — 2 reports (5.13%)
10. Renal Failure — 2 reports (5.13%)

Source database →

Frequently asked questions

Is Taxane approved in United States?

Taxane does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Taxane in United States?

Guangdong Provincial People's Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.